Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854743) titled 'Outcomes and Inter-Stage Interval in Staged Bilateral PCNL' on Sept. 27.

Study Type: Observational

Primary Sponsor: Ankara Training and Research Hospital

Condition: Nephrolithiasis

Recruitment Status: Not recruiting

Date of First Enrollment: February 1, 2022

Target Sample Size: 34

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07854743

Published by HT Digital Content Services with permission from Health Daily Digest....